Cargando…
Molecular Mechanisms and Potential New Therapeutic Drugs for Liver Fibrosis
Liver fibrosis is the pathological process of excessive extracellular matrix deposition after liver injury and is a precursor to cirrhosis, hepatocellular carcinoma (HCC). It is essentially a wound healing response to liver tissue damage. Numerous studies have shown that hepatic stellate cells play...
Autores principales: | Wang, Fa-Da, Zhou, Jing, Chen, En-Qiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8874120/ https://www.ncbi.nlm.nih.gov/pubmed/35222022 http://dx.doi.org/10.3389/fphar.2022.787748 |
Ejemplares similares
-
Research Progress in the Molecular Mechanisms, Therapeutic Targets, and Drug Development of Idiopathic Pulmonary Fibrosis
por: Ma, Hongbo, et al.
Publicado: (2022) -
Editorial: Molecular Mechanisms and New Therapeutic Targets in Epithelial to Mesenchymal Transition (EMT) and Fibrosis
por: Battistelli, Cecilia, et al.
Publicado: (2020) -
Editorial: Molecular mechanisms and new therapeutic targets in epithelial to mesenchymal transition (EMT) and fibrosis, volume II
por: Battistelli, Cecilia, et al.
Publicado: (2022) -
The Role of Nrf2 in Liver Disease: Novel Molecular Mechanisms and Therapeutic Approaches
por: Xu, Dongwei, et al.
Publicado: (2019) -
Cellular Mechanisms of Liver Fibrosis
por: Acharya, Pragyan, et al.
Publicado: (2021)